KYTX- Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc. (KYTX) has 11 insiders with recent SEC Form 4 filings, including 6 buys and 1 sell. KYTX is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 869.3K | $8.08M | - | |
| Dir | 869.3K | $8.08M | - | |
| CFO | 450.0K | $4.19M | - | |
| Other | 300.0K | $2.79M | - | |
| Other | 70.9K | $659.7K | - |
Activity
Buys and sells only
Transactions
6 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | Westlake Biopartners Opportunity Fund I, L.P. | 10% Owner | Buy | 133,333 | $7.50 | $999,997.50 | +18.1% | +22.0% | - | |
| Dec 18, 2025 | Seidenberg Beth C75 | Director | Buy | 133,333 | $7.50 | $999,997.50 | +18.1% | +22.0% | - | |
| Dec 15, 2025 | Walker Karen Marie | Chief Technology Officer | Sale+OE | 23,998 | $12.20 | $292,775.60 | -51.5% | -16.0% | - | |
| Feb 12, 2024 | Vida Ventures, LLC | 10% Owner | Buy | 253,136 | $22.00 | $5,568,992.00 | New | -51.1% | -90.2% | |
| Feb 12, 2024 | Northpond Ventures III Gp, LLC | Former 10% Owner | Buy | 450,000 | $22.00 | $9,900,000.00 | New | -51.1% | -90.2% | |
| Feb 12, 2024 | Bain Capital Life Sciences Investors, LLC | 10% Owner | Buy | 450,000 | $22.00 | $9,900,000.00 | +16.6% | -51.1% | -90.2% |